EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

Series type: Ad hoc publication

Summary

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the EMCDDA instigated a mixed-method trendspotter study to investigate the current situation. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug consumption patterns and drug-related harms during the early stages of the pandemic.

Download as PDF

Table of contents

  • Summary
  • Introduction
  • The trendspotter methodology
  • Results
  • What next?
  • References
  • Resources on COVID-19

Main subject:

drug situation

Target audience:

policymakerresearcher

Publication cover
Pages: 
27
Price: 
Free
Loading